Abstract:Aim To elucidate the pathway of fucoidan entering foam cells and the mechanism of regulating transcription factor EB (TFEB) to reduce lipid accumulation. Methods The foam cell model was established by inducing RAW264.7 macrophages with oxidized low density lipoprotein (ox-LDL). Oil red O staining and cholesterol content determination were used to assess lipid accumulation following fucoidan treatment. Four endocytosis inhibitors (CPZ, mβCD, EIPA and Colchicine) were employed, combined with Oil red O staining, cholesterol detection and Western blotting, to analyze the effects of fucoidan on intracellular lipid accumulation and TFEB nuclear translocation. The mammalian target of rapamycin (mTOR) agonist MHY1485 and the calcineurin inhibitor CsA were utilized to investigate their roles in lipid accumulation and TFEB nuclear translocation. Lysosomal function was assessed using Lyso-Tracker Red staining, and the expression of autophagy-lysosome pathway-related genes (AP-3, AP-4, MCOLN1 and LAMP-2) was determined by qRT-PCR and Western blot. Results Low and high doses of fucoidan significantly reduced the lipid accumulation in foam cells, and the cholesterol ester content decreased from 60.05% of the model group to 34.32% and 27.71% respectively (all P<0.001). After treatment with endocytic inhibitors CPZ, EIPA, mβCD and Colchicine, cholesterol contents increased by 21.67%, 10.58%, 2.10% and 36.83%, respectively (P<0.05 or P<0.001), consistent with the results of Oil red O staining. Fucoidan significantly increased the expression of TFEB in the nucleus; CPZ, EIPA and Colchicine treatments reduced nuclear TFEB by 24.02%, 12.70% and 47.79%, respectively (P<0.05 or P<0.001), while mβCD had no significant effect. After treatment with CsA and MHY1485, the nuclear TFEB decreased by 26.12% and 50.02%, respectively (P<0.05 or P<0.001); Oil red O showed a large number of lipid droplets, and the cholesterol ester contents were significantly increased compared to the control group and fucoidan group (all P<0.001), similar to the model group. Lyso-Tracker Red detection showed that fucoidan significantly enhanced lysosome function and upregulated the expression of autophagy-lysosome pathway-related genes AP-3, AP-4, MCOLN1 and LAMP-2, with LAMP-2 protein expression upregulated by 34.0% and 65.6% (P<0.05 or P<0.01). Conclusion Fucoidan enters foam cells through the clathrin-dependent endocytosis and macropinocytosis pathway, inhibits the activation of mTOR, enhances the activity of PPP3/calcineurin, promotes the dephosphorylation and translocation of TFEB into the nucleus, and then upregulates the expression of autophagy-lysosome pathway-related genes (AP-3, AP-4, MCOLN1 and LAMP-2), enhances the lysosomal function, and ultimately effectively reduces the lipid accumulation in foam cells.